Targovax ASA logo

TRVX - Targovax ASA News Story

NOK6.33 -0.0  -0.2%

Last Trade - 11:26am

Sector
Healthcare
Size
Micro Cap
Market Cap £41.6m
Enterprise Value £35.8m
Revenue £221k
Position in Universe 1021st / 1792

BRIEF-Targovax Contemplates Private Placement

Wed 22nd January, 2020 3:40pm
Jan 22 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX ASA - CONTEMPLATED PRIVATE PLACEMENT
    * TARGOVAX ASA - CONTEMPLATES A PRIVATE PLACEMENT BY ISSUING
UP TO
12,627,684 NEW SHARES IN COMPANY
    * TARGOVAX ASA - COMPANY INTENDS TO USE NET PROCEEDS FROM
PRIVATE
PLACEMENT TO FINANCE ITS ONGOING CLINICAL DEVELOPMENT IN
MESOTHELIOMA, MELANOMA AND PERITONEAL CANCER
    * TARGOVAX ASA - COMPANY INTENDS TO USE NET PROCEEDS TO
EXTEND
CASH RUNWAY THROUGH 2020
    * TARGOVAX ASA - COMPANY INTENDS TO USE NET PROCEEDS FOR
MANUFACTURING DEVELOPMENT ACTIVITIES AND GENERAL CORPORATE
PURPOSES
    * TARGOVAX ASA - SUBSCRIPTION PRICE IN PRIVATE PLACEMENT IS
NOK
8.00
    * TARGOVAX ASA - GROSS PROCEEDS FROM CONTEMPLATED ISSUE
APPROXIMATELY NOK 101 MILLION SUBJECT TO ALL SHARES BEING ISSUED

Source text for Eikon:  ID:nWkr42rkWC 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.